Skip to main content

AtriCure, Inc.

ATRC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001323885

In the last 90 days, AtriCure, Inc. insiders filed 0 open-market purchases and 10 sales; 251 institutions reported holding it in 13F filings for Q2 2026, worth $1.47B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by AtriCure, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
8 insiders, $3.32M in total
Insiders trading
8
Net value
−$3.32M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for AtriCure, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for AtriCure, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Privitera SalvatoreChief Technical Officer142,745Sep 24, 20265
Groves Regina EDirector34,546Sep 14, 20262
Dahlquist Karl S.Chief Legal Officer87,319Aug 26, 20263
Prange KarenDirector22,809Aug 7, 20263
Yuen MaggieDirector14,015Aug 7, 20263
Carrel Michael HPresident, CEO, & Director774,434Aug 3, 20266
Doraiswamy VinayakChief Scientific Officer86,511Jul 30, 20265
Wehrwein SvenDirector40,518Jul 30, 20263
Noznesky Justin JChief Mktg & Strategy Officer100,219Jul 30, 20263
Seith Douglas JChief Operating Officer229,867Jul 2, 20263
Johnson B KristineDirector55,954May 20, 20261
White Robert S.Director128,318May 20, 20262
Telman Deborah HDirector28,328May 20, 20261
Nachman ShlomoDirector24,655May 20, 20261
Wirick Angela LChief Financial Officer204,893Mar 3, 20261
Yount Deborah LeeChief Human Resources Officer45,578Mar 4, 20250
Collar Mark ADirector100,871Mar 15, 20230
Austin TonyaChief Human Resources Officer17,621May 17, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 18, 2026 (view filing)May 153 daysDoraiswamy VinayakChief Scientific OfficerSSale−5.00K$28.13−$140.7K−5.2%91.9K after
May 22, 2026 (view filing)May 202 daysPrange KarenDirectorSSale−3.00K$28.65−$86.0K−10.2%26.4K after
Jul 30, 2026 (view filing)4:57 PM ETJul 291 dayNoznesky Justin JChief Mktg & Strategy OfficerSSale−6.18K$38.80−$239.9K−5.8%100.2K after
Jul 30, 2026 (view filing)4:57 PM ETJul 282 daysWehrwein SvenDirectorSSale−25.0K$37.84−$946.0K−38.2%40.5K after
Jul 30, 2026 (view filing)4:57 PM ETJul 282 daysDoraiswamy VinayakChief Scientific OfficerSSale−6.00K$38.88−$233.3K−6.5%86.5K after
Aug 7, 2026 (view filing)9:18 AM ETAug 52 daysYuen MaggieDirectorSSale−3.50K$38.42−$134.5K−20.0%14.0K after
Aug 7, 2026 (view filing)9:18 AM ETAug 52 daysPrange KarenDirectorSSale−3.56K$38.80−$138.3K−13.5%22.8K after
Aug 26, 2026 (view filing)6:50 AM ETAug 242 daysDahlquist Karl S.Chief Legal OfficerSSale−9.37K$48.89−$458.1K−9.7%87.3K after
Sep 4, 2026 (view filing)7:39 AM ETSep 22 daysPrivitera SalvatoreChief Technical OfficerSSale−7.76K$52.50−$407.6K−4.9%150.9K after10b5-1
Sep 10, 2026 (view filing)9:18 AM ETSep 82 daysPrivitera SalvatoreChief Technical OfficerSSale−3.66K$55.00−$201.1K−2.4%147.3K after10b5-1
Sep 14, 2026 (view filing)5:44 PM ETSep 113 daysGroves Regina EDirectorSSale−5.31K$54.22−$288.1K−13.3%34.5K after
Sep 24, 2026 (view filing)5:00 PM ETSep 231 dayPrivitera SalvatoreChief Technical OfficerSSale−4.52K$60.00−$271.1K−3.1%142.7K after10b5-1